UNITED STATES SECURITIES AND EXCHANGE COMMISSION
|
Washington, DC 20549
|
______________________
|
FORM 8-K
|
CURRENT REPORT PURSUANT
|
TO SECTION 13 OR 15(D) OF THE
|
SECURITIES EXCHANGE ACT OF 1934
|
July 17, 2014
|
Date of Report (Date of earliest event reported)
|
BOVIE MEDICAL CORPORATION
|
(Exact name of registrant as specified in its Charter)
|
Delaware
|
012183
|
11-2644611
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
5115 Ulmerton Rd., Clearwater, Florida 33760
|
(Address of principal executive offices) (Zip Code)
|
(800) 537-2790
|
Registrant's telephone number, including area code
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Name of Directors
|
Votes For
|
Votes Withheld
|
Andrew Makrides
|
9,671,009
|
237,565
|
Robert L. Gershon
|
9,747,965
|
160,609
|
J. Robert Saron
|
9,240,087
|
668,487
|
Michael Geraghty
|
9,288,601
|
619,973
|
Ian Sheffield
|
9,723,285
|
160,284
|
Lawrence J. Waldman
|
9,246,972
|
661,602
|
John C. Andres
|
9,269,785
|
613,784
|
Votes For
|
Votes Against
|
Votes Abstained
|
9,216,523
|
600,064
|
91,987
|
Votes For
|
Votes Against
|
Votes Abstained
|
8,806,103
|
1,052,357
|
50,114
|
Date: July 21, 2014
|
BOVIE MEDICAL CORPORATION
|
||
By: /s/ Robert Gershon
|
|||
Robert Gershon
|
|||
Chief Executive Officer
|